FDA
approval
· 2021-03-18
FDA Approved: CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% — Supplemental Application (Encube Ethicals, Inc.)
Summary
FDA approves a supplemental application for CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (ANDA 209914) by Encube Ethicals, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1%)